Market Research Reprots- Worldwide In Situ Hybridization Market | Page 2

Request for sample of this research report @ https://marketreportscenter.com/request-
sample/580177
Advances in RNA in situ hybridization transform molecular detection with morphological
context enabling new applications. Scientists use RNA ISH to extract data dimensions.
Immunohistochemistry (IHC) and RNA in situ Hybridization are widely used technologies
sharing the unique capacity to analyze a marker at the single cell level while preserving the
morphological context. In different situations, IHC and ISH are used in conjunction to validate
data or provide complementary information.
In situ hybridization (ISH) is a powerful technique for localizing specific nucleic acid targets
within fixed tissues and cells, allowing users to obtain temporal and spatial information about
gene expression and genetic loci. While the basic workflow of ISH is similar to that of blot
hybridizations the nucleic acid probe is synthesized, labeled, purified, and annealed with the
specific target the difference is the greater amount of information gained by visualizing the
results within the tissue.
The global market for In Situ Hybridization (ISH) at $4.3 billion in 2017 is anticipated to reach
$7.8 billion by 2024 2017. CAGR of 7.8% in the next five years (2017 to 2024). Increasing
diagnosis and growing incidence & prevalence of cancer, technology advancements in
therapeutics, increasing government initiatives globally are expected to drive the growth of the
market in the coming years.
Key Topics











In Situ Hybridization
Molecular Diagnostics
Cervical Cancer Stain
Fish Steps Reduction
Fluorescence In Situ Hybridization (FISH)
In Situ Hybridization (ISH)
FISH Probe Kit
Cancer
Chromosonal Abnormalities
Infectious Diseases
Inflammatory Diseases